Integrated bulk and single-cell transcriptomes reveal pyroptotic signature in prognosis and therapeutic options of hepatocellular carcinoma by combining deep learning

被引:6
|
作者
Liu, Yang [1 ]
Li, Hanlin [1 ]
Zeng, Tianyu [1 ]
Wang, Yang [1 ]
Zhang, Hongqi [2 ]
Wan, Ying [1 ]
Shi, Zheng [3 ,4 ]
Cao, Renzhi [5 ]
Tang, Hua [1 ,6 ]
机构
[1] Southwest Med Univ, Sch Basic Med Sci, Luzhou, Peoples R China
[2] Univ Elect Sci & Technol China, Ctr Informat Biol, Sch Life Sci & Technol, Chengdu, Peoples R China
[3] Chengdu Univ, Clin Med Coll, Clin Genet Lab, Chengdu 610106, Peoples R China
[4] Chengdu Univ, Affiliated Hosp, Chengdu 610106, Peoples R China
[5] Pacific Lutheran Univ, Dept Comp Sci, Tacoma, WA 98447 USA
[6] Minist Educ, Basic Med Res Innovat Ctr Cardiometab Dis, Luzhou 646000, Peoples R China
基金
中国国家自然科学基金;
关键词
pyroptosis; hepatocellular carcinoma; attention mechanism; tumor microenvironment; scRNA-seq; precision medicine; CANCER; TUMORIGENESIS; EXPRESSION; DIVERSITY; STEMNESS; PATHWAY; GROWTH; AXIS; YAP;
D O I
10.1093/bib/bbad487
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Although some pyroptosis-related (PR) prognostic models for cancers have been reported, pyroptosis-based features have not been fully discovered at the single-cell level in hepatocellular carcinoma (HCC). In this study, by deeply integrating single-cell and bulk transcriptome data, we systematically investigated significance of the shared pyroptotic signature at both single-cell and bulk levels in HCC prognosis. Based on the pyroptotic signature, a robust PR risk system was constructed to quantify the prognostic risk of individual patient. To further verify capacity of the pyroptotic signature on predicting patients' prognosis, an attention mechanism-based deep neural network classification model was constructed. The mechanisms of prognostic difference in the patients with distinct PR risk were dissected on tumor stemness, cancer pathways, transcriptional regulation, immune infiltration and cell communications. A nomogram model combining PR risk with clinicopathologic data was constructed to evaluate the prognosis of individual patients in clinic. The PR risk could also evaluate therapeutic response to neoadjuvant therapies in HCC patients. In conclusion, the constructed PR risk system enables a comprehensive assessment of tumor microenvironment characteristics, accurate prognosis prediction and rational therapeutic options in HCC.
引用
收藏
页数:15
相关论文
共 50 条
  • [1] Integrated Analysis of Bulk and Single-Cell RNA Sequencing Data Reveal a Novel Prognostic Signature of Combining Cuproptosis- and Ferroptosis-Related Genes in Hepatocellular Carcinoma
    Wei, Hua
    Peng, Jiaxin
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2025, 26 (06)
  • [2] Single-Cell and Bulk Transcriptomics Reveal the Immunosenescence Signature for Prognosis and Immunotherapy in Lung Cancer
    Zhang, Yakun
    Zhou, Jiajun
    Jin, Yitong
    Liu, Chenyu
    Zhou, Hanxiao
    Sun, Yue
    Jiang, Han
    Gan, Jing
    Zhang, Caiyu
    Lu, Qianyi
    Chang, Yetong
    Zhang, Yunpeng
    Li, Xia
    Ning, Shangwei
    CANCERS, 2025, 17 (01)
  • [3] Combining bulk and single-cell RNA-sequencing data to develop an NK cell-related prognostic signature for hepatocellular carcinoma based on an integrated machine learning framework
    Feng, Qian
    Huang, Zhihao
    Song, Lei
    Wang, Le
    Lu, Hongcheng
    Wu, Linquan
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2023, 28 (01)
  • [4] Combining bulk and single-cell RNA-sequencing data to develop an NK cell-related prognostic signature for hepatocellular carcinoma based on an integrated machine learning framework
    Qian Feng
    Zhihao Huang
    Lei Song
    Le Wang
    Hongcheng Lu
    Linquan Wu
    European Journal of Medical Research, 28
  • [5] Integrated analysis of single-cell and bulk RNA-sequencing identifies a signature based on NK cell marker genes to predict prognosis and immunotherapy response in hepatocellular carcinoma
    Dashuai Yang
    Fangrui Zhao
    Yang Su
    Yu Zhou
    Jie Shen
    Bin Yu
    Kailiang Zhao
    Youming Ding
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 10609 - 10621
  • [6] Integrated analysis of single-cell and bulk transcriptome identifies a signature based on NK cell marker genes to predict prognosis and therapeutic response in clear cell renal cell carcinoma
    Wang, Ke
    Yu, Mingyang
    Zhang, Zhouzhou
    Yin, Rong
    Chen, Qifeng
    Zhao, Xuezhi
    Yu, Hongqi
    TRANSLATIONAL CANCER RESEARCH, 2023, 12 (05) : 1270 - +
  • [7] Integrated analysis of single-cell and bulk RNA-sequencing identifies a signature based on NK cell marker genes to predict prognosis and immunotherapy response in hepatocellular carcinoma
    Yang, Dashuai
    Zhao, Fangrui
    Su, Yang
    Zhou, Yu
    Shen, Jie
    Yu, Bin
    Zhao, Kailiang
    Ding, Youming
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (12) : 10609 - 10621
  • [8] Integrated analysis of single-cell and bulk RNA-sequencing reveals tumor heterogeneity and a signature based on NK cell marker genes for predicting prognosis in hepatocellular carcinoma
    Li, Shuo
    Du, Hongbo
    Gan, Da'nan
    Li, Xiaoke
    Zao, Xiaobin
    Ye, Yong'an
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [9] Comparison of single-nucleus and single-cell transcriptomes in hepatocellular carcinoma tissue
    Wen, Fei
    Tang, Xiaojie
    Xu, Lin
    Qu, Haixia
    MOLECULAR MEDICINE REPORTS, 2022, 26 (05)
  • [10] Integrated analysis of single-cell and bulk RNA sequencing data reveals a cellular senescence-related signature in hepatocellular carcinoma
    Qiao, Lei
    Xu, Zibo
    Chen, Yuheng
    Chen, Wenwei
    Liang, Yuan
    Wei, Yi
    Wang, Kang
    Yu, Yue
    Yan, Wei
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2024, 12